Category: antiCD89
-
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
•
This section is Partnership content provided The content in this section is provided by Business Wire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Business wire Breadcrumb links PMN press releases Business newsletters Article writer: Posted on May 29,…